Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 3Withdrawn 1Unknown 1Terminated 1

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Observational 3Interventional 3

Sponsor

Cancer Type

Genitourinary 6Gastrointestinal 1Breast 1

Conditions

Neoplasms 10Lung Neoplasms 9Colorectal Neoplasms 7Breast Neoplasms 7Prostatic Neoplasms 6Rectal Neoplasms 3Polycystic Ovary Syndrome 3Neoplasm Metastasis 3Colonic Neoplasms 3Stomach Neoplasms 2Smoking Cessation 2Neoplastic Cells, Circulating 2Motor Activity 2Lymphoma 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia 2Endometrial Neoplasms 2Disease 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Venous Thromboembolism 1Vaginal Neoplasms 1Uveal Melanoma 1Uterine Cervical Neoplasms 1Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer 1Testicular Germ Cell Tumor 1Stroke 1Solitary Pulmonary Nodule 1Skin Neoplasms 1Sezary Syndrome 1

Interventions

Docetaxel 171Radiotherapy 144Magnetic Resonance Spectroscopy 142Leuprolide 112Prednisone 108enzalutamide 102Radiosurgery 101Abiraterone Acetate 94Androgen Antagonists 91Goserelin 83bicalutamide 81gallium 68 PSMA-11 70Surveys and Questionnaires 63apalutamide 57Specimen Handling 56acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 55Radiation 47Gonadotropin-Releasing Hormone 45Standard of Care 44Biopsy 44Brachytherapy 42Radiotherapy, Intensity-Modulated 40Blood Specimen Collection 40darolutamide 39abiraterone 39cabazitaxel 35Exercise 35Carboplatin 33Pluvicto 32Triptorelin Pamoate 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × Prostatic Neoplasms × Hematologic Tests × Clear all
NCT03568188 2026-02-24

FOCALE

Hospices Civils de Lyon

Phase 2 Completed
174 enrolled
Genitourinary

Prostatic Neoplasms

NCT03284684 2025-12-01

Periop ctDNA

Centre Hospitalier Universitaire de Nīmes

Completed
30 enrolled
BreastGastrointestinalGenitourinary

Breast Neoplasms, Colonic Neoplasms, Prostatic Neoplasms

NCT02346526 2022-09-29

A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer

Massachusetts General Hospital

Phase 2 Completed
22 enrolled 14 charts
Genitourinary

Prostatic Neoplasms

NCT02747563 2016-04-21

Evaluation of PSA Blood Levels Prior to and After Digital Rectal Examination

Kaplan Medical Center

Phase 1 Unknown
60 enrolled
Genitourinary

Prostatic Neoplasms

NCT00523471 2016-02-26

Blood Test to Measure DNA Damage in Blood

AHS Cancer Control Alberta

Terminated
40 enrolled
Genitourinary

Prostatic Neoplasms

NCT01838265 2014-12-08

MGM

University of Miami

Withdrawn
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡